Reaction of SrI 2, EuI 2 (THF) 2, and YbI 2 (THF) 2 with KN(SiMe 3 ) 2 and [{( i Pr) 2 ATI}K] (( i Pr) 2 ATI = N -isopropyl-2-(isopropylamino)troponiminate) led to monoaminotroponiminate complexes of the heavier alkaline earth elements and the related divalent lanthanides of composition [{( i Pr) 2 ATI}M{N(SiMe 3 ) 2 }(THF) 2 )] (M = Sr, Eu, Yb). Diaminotroponiminate complexes of composition [{( i Pr) 2 ATI} 2 M(THF) 2 )] (M = Sr, Ba) were obtained by the reaction of SrI 2 and BaI 2 with 2 equiv of [{( i Pr) 2 ATI}K]. All new compounds were characterized by single-crystal X-ray diffraction. Independent of the ionic radius of the center metal all monoaminotroponiminate complexes [{( i Pr) 2 ATI}M{N(SiMe 3 ) 2 }(THF) 2 ] including the previously reported Ca analogue are isostructural. The same phenomenon is observed for [{( i Pr) 2 ATI} 2 M(THF) 2 )]. The heterolepetic compounds [{( i Pr) 2 ATI}M{N(SiMe 3 ) 2 }(THF) 2 )] were used as catalysts for the intramolecular hydroamination/cyclization reaction of nonactivated aminoalkenes. A decrease in the rate with increasing ion radius of the center metal is observed for the alkaline earth elements. The ytterbium complex, which is oxidized during the catalytic conversion, is also an efficient precatalyst for the hydroamination/cyclization reaction.
No takes yet. Share an insight, caveat, or question.
Datta et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: